ELDN
Price:
$2.68
Market Cap:
$106.28M
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2...[Read more]
Industry
Biotechnology
IPO Date
2014-09-17
Stock Exchange
NASDAQ
Ticker
ELDN
According to Eledon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 5.96. This represents a change of -672.54% compared to the average of -1.04 of the last 4 quarters.
The mean historical PE Ratio of Eledon Pharmaceuticals, Inc. over the last ten years is -1.57. The current 5.96 PE Ratio has changed -37987.56% with respect to the historical average. Over the past ten years (40 quarters), ELDN's PE Ratio was at its highest in in the September 2016 quarter at -0.03. The PE Ratio was at its lowest in in the December 2014 quarter at -13.25.
Average
-1.57
Median
-1.06
Minimum
-4.35
Maximum
-0.09
Discovering the peaks and valleys of Eledon Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.53%
Maximum Annual PE Ratio = -0.09
Minimum Annual Increase = -97.96%
Minimum Annual PE Ratio = -4.35
Year | PE Ratio | Change |
---|---|---|
2023 | -1.10 | 195.23% |
2022 | -0.37 | -80.35% |
2021 | -1.89 | 93.29% |
2020 | -0.98 | 155.98% |
2019 | -0.38 | -62.63% |
2018 | -1.02 | -29.25% |
2017 | -1.45 | 1.53% |
2016 | -0.09 | -97.96% |
2015 | -4.35 | 6.24% |
2014 | -4.09 | -82.36% |
The current PE Ratio of Eledon Pharmaceuticals, Inc. (ELDN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.12
5-year avg
-0.95
10-year avg
-1.57
Eledon Pharmaceuticals, Inc.’s PE Ratio is greater than Inozyme Pharma, Inc. (-3.62), greater than Day One Biopharmaceuticals, Inc. (-7.22), greater than Terns Pharmaceuticals, Inc. (-5.96), greater than HOOKIPA Pharma Inc. (-0.96), greater than X4 Pharmaceuticals, Inc. (5.82), greater than Acumen Pharmaceuticals, Inc. (-2.18), greater than Amylyx Pharmaceuticals, Inc. (-1.46), greater than Mereo BioPharma Group plc (-18.26),
Company | PE Ratio | Market cap |
---|---|---|
-3.62 | $324.96M | |
-7.22 | $1.22B | |
-5.96 | $647.62M | |
-0.96 | $44.72M | |
5.82 | $86.22M | |
-2.18 | $141.19M | |
-1.46 | $241.69M | |
-18.26 | $667.34M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eledon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eledon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Eledon Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Eledon Pharmaceuticals, Inc. (ELDN)?
What is the highest PE Ratio for Eledon Pharmaceuticals, Inc. (ELDN)?
What is the 3-year average PE Ratio for Eledon Pharmaceuticals, Inc. (ELDN)?
What is the 5-year average PE Ratio for Eledon Pharmaceuticals, Inc. (ELDN)?
How does the current PE Ratio for Eledon Pharmaceuticals, Inc. (ELDN) compare to its historical average?